Target was hit with a class action suit claiming the retailer duped investors about the company's DEI policies and tricked them into buying stock at an artificially inflated price.

Target has been sued for allegedly concealing the risks of its diversity and social initiatives, leading to a backlash that ...

Target Corporation, CEO Brian Cornell and current and former board members have been sued for defrauding stockholders about ...

Target has been sued for allegedly concealing the risks of its diversity initiatives, leading to a backlash that caused the ...

Genetically modified pig kidneys begin trials for 50 U.S. kidney failure patients FDA launches clinical trials for organ ...

Kirkland Signature Smoked Salmon products that were recalled in October 2024 have officially been re-classified by the U.S.

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

A day after opening fire on an armored U.S. embassy van and wounding a local hire, armed gangs in Haiti on Tuesday fired on three vehicles, two of them armored and fitted with diplomatic plates, and ...

Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...

Manufacturers will no longer be allowed to use the dye, called red No 3 or red dye 3, after studies linked it to cancer in male laboratory rats, the US Food and Drug Administration (FDA ...